TCN-350

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTCN-350

Drug Alias Nameanti-GM-CSF human mAbs (Theraclone Sciences)anti-GM-CSF human monoclonal antibodies (Theraclone Sciences)Human antibodies (GM-CSF, Spaltudaq)TCN-350

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionMacrophage colony stimulating factor 2 inhibitors

TargetsMacrophage colony stimulating factor 2

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTheraclone Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTheraclone Sciences Inc

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A